Hepatitis-B Vaccination
M/s Shantha Biotechnics Pvt. Ltd, Hyderabad
This was the first commercial enterprise with which TDB signed an agreement for providing loan assistance to develop and commercialise a product- Hepatitis-B vaccine on 9th April, 1997. ‘Hepatitis-B’ is a viral infection of the liver and a major health problem in India. The company launched India’s first genetically engineered human health care product ‘Shanvac-B’ in August 1997. The product is import substitute and cost effective.
About the Technology
The company has indigenously developed the technology for tetravalent vaccine ‘DPT and Hepatitis-B’ and has successfully started the commercial production of the vaccine.
The company was the first recipient of the National Award by TDB in the year 2000.
Date to place
color change
No
